CRPC

Open Access
Immediate Prostate-specific Antigen Decline After Enzalutamide Following Abiraterone Predicts Survival in Castration-resistant Disease
NAOHIRO FUJIMOTO, AKINORI MINATO, TSUKASA IGAWA, TASUKU HIROSHIGE, WATARU OBARA, ATSUSHI FUKUDA, YUJIRO NAGATA, YUI MIZUSHIMA, IKKO TOMISAKI and KENICHI HARADA

Anticancer Research June 2022, 42 (6) 3041-3047; DOI: https://doi.org/10.21873/anticanres.15790
You have access
Clinical Outcome and Prognostic Variables of Second-line Therapy for Patients With Castration-resistant Prostate Cancer After Failure of First-line Androgen Receptor Axis-targeted Therapy
MOTOHIRO FUJIWARA, RYO FUJIWARA, TOMOHIKO OGUCHI, YOSHINOBU KOMAI, NOBORU NUMAO, SHINYA YAMAMOTO, JUNJI YONESE and TAKESHI YUASA

Anticancer Research April 2022, 42 (4) 2123-2130; DOI: https://doi.org/10.21873/anticanres.15694
You have access
ANO7 rs77559646 Is Associated With First-line Docetaxel Treatment Response in Metastatic Castration-resistant Prostate Cancer
ELINA KAIKKONEN, OTTO ETTALA, ILKKA NIKULAINEN, PEKKA TAIMEN, ILARI LEHTINEN, PETER J. BOSTRÖM, PIRKKO-LIISA KELLOKUMPU-LEHTINEN and JOHANNA SCHLEUTKER

Anticancer Research October 2019, 39 (10) 5353-5359; DOI: https://doi.org/10.21873/anticanres.13728
You have access
Low-dose Docetaxel Enhanced the Anticancer Effect of Temsirolimus by Overcoming Autophagy in Prostate Cancer Cells
SO INAMURA, HIDEAKI ITO, MINEKATSU TAGA, KATSUKI TSUCHIYAMA, HITOMI HOSHINO, MOTOHIRO KOBAYASHI and OSAMU YOKOYAMA

Anticancer Research October 2019, 39 (10) 5417-5425; DOI: https://doi.org/10.21873/anticanres.13735
You have access
Synthesis and Binding of a Novel PSMA-specific Conjugate
ANDERS R. HOLMBERG, MARCELA MARQUEZ, LENA LENNARTSSON, LENNART MEURLING and STEN NILSSON

Anticancer Research March 2018, 38 (3) 1531-1537;
You have access
Combining Abiraterone and Radiotherapy in Prostate Cancer Patients Who Progressed During Abiraterone Therapy
BEATRICE DETTI, ROLANDO M. D'ANGELILLO, GIANLUCA INGROSSO, EMANUELA OLMETTO, GIULIO FRANCOLINI, LUCA TRIGGIANI, ALESSIO BRUNI, SIMONA BORGHESI, SIMONA FONDELLI, TOMMASO CARFAGNO, ROBERTO SANTINI, RICCARDO SANTONI, LUCA E. TRODELLA and LORENZO LIVI

Anticancer Research July 2017, 37 (7) 3717-3722;
You have access
Bone-targeted Novel Cytotoxic Polybisphosphonate Conjugate in Castration-resistant Prostate Cancer: A Multicenter Phase 1 Study
CAMILLA THELLENBERG-KARLSSON, CLAES NYMAN, STEN NILSSON, RENÉ BLOM, MARCELA MÁRQUEZ, ENRIQUE CASTELLANOS and ANDERS R. HOLMBERG

Anticancer Research December 2016, 36 (12) 6499-6504;
You have access
Predictive Factors for Response to Abiraterone in Metastatic Castration Refractory Prostate Cancer
MEHRAN AFSHAR, FAWAZ AL-ALLOOSH, SARAH PIRRIE, CLARE ROWAN, NICHOLAS D. JAMES and EMILIO PORFIRI

Anticancer Research February 2015, 35 (2) 1057-1063;
You have access
Expression of Hepatocyte Growth Factor Activator Inhibitor Type-1 (HAI-1) in Prostate Cancer
KENJI YASUDA, AKIRA KOMIYA, AKIHIKO WATANABE, AKIHIRO MORII, TAKESHI OYA, OSAMU NAGAKAWA, YASUYOSHI FUJIUCHI and HIDEKI FUSE

Anticancer Research February 2013, 33 (2) 575-581;

Main menu

User menu

Search

CRPC